Infectious Diseases Therapy
Investigators at University of Pittsburgh, Division of Infectious Diseases release new data on infectious diseases therapy
Published in Genetics and Environmental Health Week, March 10th, 2010
Scientists discuss in 'Low frequency nonnucleoside reverse-transcriptase inhibitor-resistant variants contribute to failure of efavirenz-containing regimens in treatment- experienced patients' new findings in infectious diseases. According to recent research published in the Journal of Infectious Diseases, "The contribution of low frequency drug-resistant human immunodeficiency virus type 1 (HIV-1) variants to failure of antiretroviral therapy is not well defined in treatment-experienced patients. We sought to detect minor nonnucleoside reverse-transcriptase inhibitor (NNRTI)-resistant variants at the initiation of multidrug efavirenz-containing therapy in both NNRTI-naive and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Health Week
More Articles from Genetics and Environmental Health Week
- Age and Aging
Findings from University of Florida, Institute on Aging broaden understanding of age and aging - Arthritis Immunology
Researchers at Royal Children's Hospital have published new data on arthritis immunology - Autism
Reports on autism findings from McLean Hospital provide new insights - Bioengineering
Investigators at University of Sydney zero in on bioengineering - Bipolar Disorder Genetics
Researchers from RIKEN publish findings in bipolar disorder genetics - Breast Cancer Therapy
Studies from University of Modena have provided new information about breast cancer therapy - More from this issue of Genetics and Environmental Health Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
